SHELLIE HENDREN: Open Payments
NPI 1841470366 · MUNFORD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 21 payments from 9 companies in 2025. Trend: 2023 $111 · 2024 $291 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 5 | $108 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| ABBVIE INC. | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: ARISTADA, INVEGA SUSTENNA, UZEDY, VRAYLAR, COBENFY, HETLIOZ, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
